Latest News in the pharma Industry

Top Stories

Croda celebrates EXCiPACT Certification across all leading excipient sites

Croda celebrates EXCiPACT Certification across all leading excipient sites

10 May 2017

Status marks the company as the first multi-site excipient supplier to achieve global EXCiPACT accreditation across its production facilities.

Read more 
Chemotherapy as a tablet instead of an intravenous infusion

Chemotherapy as a tablet instead of an intravenous infusion

28 Mar 2017

New production method for solid dispersions of docetaxel and paclitaxel.

Read more 
Landmark outcomes study shows that Repatha  decreases LDL-C to unprecedented low levels

Landmark outcomes study shows that Repatha decreases LDL-C to unprecedented low levels

17 Mar 2017

Amgen has announced that the 27,564-patient Repatha (evolocumab) cardiovascular outcomes study, FOURIER, established for the first time that maximally reducing low-density lipoprotein cholesterol (LDL-C) levels with Repatha, beyond what is possible wit...

Read more 
Mylan announces global settlement and license Agreements with Genentech and Roche on Herceptin

Mylan announces global settlement and license Agreements with Genentech and Roche on Herceptin

13 Mar 2017

Settlement provides Mylan with global licenses for its trastuzumab product.

Read more 
Pharma's most innovative companies; the 2017 ranking

Pharma's most innovative companies; the 2017 ranking

28 Feb 2017

Innovation is being driven increasingly by smaller, possibly more agile, companies.

Read more 
Can yeast rise to the challenge of curing cancer?

Can yeast rise to the challenge of curing cancer?

21 Feb 2017

Modified baker’s yeasts cause an immune response and the production of lymphocyte killers, which detect and eliminate cancerous cells.

Read more 
Turbofer: innovative formulation for iron deficiency

Turbofer: innovative formulation for iron deficiency

16 Feb 2017

NTC Pharma expands its product portfolio with a new food supplement containing iron pyrophosphate microencapsulated in liposomal form, Turbofer orosoluble granules.

Read more 
Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

23 Jan 2017

The molecule, which is a PPMO, will likely be ready for testing in humans in about 3 years.

Read more 
Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease

Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease

17 Jan 2017

Therapies targeted at this novel mechanism have the potential for disease-modification because they will address the genetic root cause of AD.

Read more 
Ariad to be acquired by Takeda for $5.2 billion

Ariad to be acquired by Takeda for $5.2 billion

9 Jan 2017

Ariad stockholders to receive $24.00 per share in cash.

Read more 
Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic

Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic

16 Dec 2016

Authorized generic offered at more than 50% below wholesale acquisition cost of EpiPen auto-injector.

Read more 
Lonza to acquire Capsugel

Lonza to acquire Capsugel

15 Dec 2016

Acquisition will make Lonza a fully integrated solutions provider in oral delivery technologies and active ingredients to the consumer healthcare and nutrition markets.

Read more